December 1, 2017 · STOCK Act disclosure
Representative Lamar Smith (Republican-TX) bought Ligand Pharmaceuticals Incorporated, a stock transaction, valued at $1,001 - $15,000. The trade took place on December 1, 2017 and was disclosed on January 9, 2018 (owner: Self). Members of Congress must report such transactions within 45 days under the STOCK Act.